News | December 28, 2021
CDSCO expert committee recommends Emergency Use Authorisation to Covovax and Corbevax
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
The company will market it under the brand name Molflu
The authorization provides an additional treatment option against the Covid-19 virus in the form of a pill that can be taken orally
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
Subscribe To Our Newsletter & Stay Updated
